Home›Stock Screener›Krsnaa Diagnostics

Krsnaa Diagnostics Share Price Today | Stock Price & Krsnaa Diagnostics Share Screener

KRSNAA Healthcare Service Provider
Live Share Price NSE
₹559.35
▲ 4.50 (0.81%)
2026-10-05 00:00:00
Live Share Price BSE
₹559.25
▲ 4.85 (0.87%)
2026-10-05 00:00:00

As of October 5, 2026, the live Krsnaa Diagnostics share price (NSE: KRSNAA) is ₹559.35 on NSE and ₹559.25 on BSE, up 0.81% from the previous close, with shares trading between ₹551.30 and ₹564.10 in today's trading session, and a 52-week range of ₹520.30–₹826.80. Check KRSNAA 52-week high low for the annual price range and momentum. Use the Krsnaa Diagnostics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Krsnaa Diagnostics opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹224 and net income of ₹42, with EBITDA of ₹86, an operating margin of 28.0% and a profit margin of 18.8%.

Krsnaa Diagnostics Market Cap ₹1,795.80 Cr.
KRSNAA P/E Ratio (TTM) 17.83
Krsnaa Diagnostics P/B Ratio 1.77
EPS (TTM) ₹31.30
Dividend Yield 0.37%
Debt to Equity 0.40
KRSNAA 52 Week High ₹826.80
Krsnaa Diagnostics 52 Week Low ₹520.30
Operating Margin 28.00%
Profit Margin 18.75%
KRSNAA Revenue (TTM) ₹224.00
EBITDA ₹86.00
Net Income ₹42.00
Total Assets ₹1,824.00
Total Equity ₹980.00

Krsnaa Diagnostics Share Price Chart

Track the current stock price of Krsnaa Diagnostics with an interactive chart. Analyse KRSNAA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Krsnaa Diagnostics stock quote in one place.

The quote of ₹559.35 sits between the 52-week low of ₹520.30 and the 52-week high of ₹826.80, and the latest session moved 0.81% from the previous close.

Krsnaa Diagnostics Company Profile - Fundamental Screener

Screen Krsnaa Diagnostics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KRSNAA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE08LI01020.

Company Details

Classification

Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E

Identifiers and Leadership

ISIN INE08LI01020

Krsnaa Diagnostics Balance Sheet Screener

Screen KRSNAA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1,824, up from ₹1,282 in 2025.

Latest statistics put total assets at ₹1,824 and shareholder funds at ₹980, with a leverage ratio of 0.40.

Item 2026 2025 2024 2023 2022

Assets

Total Assets 1,824 1,282 1,172 910 876
Current Assets 738 415 421 223 334
Fixed Assets 657 670 647 471 386

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 568 93 81 72 71
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 980 883 810 739 684
Share Capital 16 16 16 16 16
Reserves & Surplus 964 867 794 723 669

Krsnaa Diagnostics Income Statement Screener - Profit & Revenue Analysis

Screen Krsnaa Diagnostics income statement and profit fundamentals. Analyze KRSNAA quarterly results. Krsnaa Diagnostics reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹224 and net profit was ₹42, equal to earnings per unit of ₹12.86, at an operating margin of 28%.

In that period expenses were ₹138, interest cost ₹12 and tax ₹10. The next period listed, 2026-Jun, shows revenue of ₹243 and net profit of ₹17.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 224 243 191 197 210 185 171 178 191 184 139 144 160 162 112
Expenses 138 178 133 142 147 135 123 128 137 129 99 108 124 121 80

Operating Costs and Margins

EBITDA 86 65 57 55 63 50 48 50 54 54 40 36 36 42 32
Operating Profit % 28.00% 25.00% 28.00% 27.00% 29.00% 26.00% 26.00% 25.00% 27.00% 26.00% 26.00% 22.00% 20.00% 24.00% 26.00%
Depreciation 23 28 22 22 24 23 18 22 22 23 15 16 20 21 10
Interest 12 15 7 6 8 8 7 5 6 6 2 2 3 4 2

Profit and Earnings

Profit Before Tax 52 22 29 27 32 20 23 23 25 26 24 18 13 16 20
Tax 10 6 8 7 8 4 4 5 6 6 5 3 3 3 2
Net Profit 42 17 21 21 24 15 19 18 20 19 19 15 11 13 18
EPS 12.86 5.10 6.40 6.35 7.38 4.72 5.80 5.55 6.07 6.01 6.03 4.66 3.35 4.09 5.40

Krsnaa Diagnostics Cash Flow Screener - Liquidity Fundamentals

Screen KRSNAA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹143, and net cash flow was an inflow of ₹26.

Over the same period, investing activities used ₹396 and financing activities provided ₹279.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities 143 87 24 76 128 64 -23
Investing Activities -396 -100 -129 -109 -241 -54 -47

Financing and Net Cash

Financing Activities 279 14 84 -33 176 -41 105
Net Cash Flow 26 2 -20 -66 64 -31 36

Krsnaa Diagnostics Shareholding Pattern Screener

See Krsnaa Diagnostics shareholding pattern with promoter, FII, and DII holdings. Check Krsnaa Diagnostics promoter holding and ownership changes for KRSNAA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 27.11%, foreign institutions 3.91%, domestic institutions 13.89% and the public 28.68%, spread across 53,022 shareholders.

The shareholder count was 53,022 in 2026-Mar, compared with 53,625 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 27.11% 27.11% 27.24% 27.11% 27.11% 27.11% 27.03% 27.17%

Institutional Investors

FII Holding 3.91% 4.28% 3.55% 3.40% 3.67% 4.17% 3.34% 3.33%
DII Holding 13.89% 14.51% 14.26% 14.24% 14.96% 13.86% 15.37% 15.26%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 28.68% 27.85% 29.13% 28.95% 27.40% 27.84% 27.72% 28.73%
Other Holding 26.40% 26.24% 25.81% 26.30% 26.86% 27.01% 26.54% 25.51%
Shareholder Count 53,022 53,625 53,559 54,262 52,117 52,380 56,458 55,914

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Krsnaa Diagnostics. Krsnaa Diagnostics dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.00 per unit for 2026-March, a yield of 0.37%, compared with ₹2.75 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.00, ₹2.75 and ₹2.50 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹2.00 0.37%
2025-March ₹2.75 0.53%
2024-March ₹2.50 0.32%
2023-March ₹2.75 0.45%
2022-March ₹2.50 0.56%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Krsnaa Diagnostics Stock Index Membership - Nifty & Sensex

See which indices include Krsnaa Diagnostics stock. Check KRSNAA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP

Krsnaa Diagnostics Market Events Screener - Corporate Actions

Get Krsnaa Diagnostics corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Krsnaa Diagnostics stock events that may affect KRSNAA share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 28, 2026, with a record date of September 28, 2026.

It is followed by Dividend dated September 18, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-28 2026-09-28 Annual General Meeting NA -0.25%
2026-09-18 2026-09-18 Dividend ₹ 2.00 /share -3.73%
2026-08-13 2026-08-13 Quarterly Result Announcement NA 2.76%
2026-05-25 2026-05-25 Quarterly Result Announcement NA -3.83%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 2.01%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -5.32%
2025-09-25 2025-09-25 Annual General Meeting NA -2.35%
2025-09-12 2025-09-12 Dividend ₹ 2.75 /share 19.21%
2025-08-11 2025-08-11 Quarterly Result Announcement NA 1.72%
2025-05-12 2025-05-12 Quarterly Result Announcement NA -0.98%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -3.19%
2024-10-25 2024-10-25 Quarterly Result Announcement NA -3.08%
2024-09-21 2024-09-21 Annual General Meeting NA 34.63%
2024-09-13 2024-09-13 Dividend ₹ 2.50 /share 30.69%
2023-09-15 2023-09-16 Dividend ₹ 2.75 /share 29.48%

Krsnaa Diagnostics Competitors Screener - Peer Stocks Comparison

Screen KRSNAA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 32,696 59.65 2,864 12.11% 510 58.55
Vijaya Diagnostic Centre 15,177 82.40 835 19.34% 173 47.24
Metropolis Healthcare 11,658 58.51 1,671 24.15% 191 40.73
Thyrocare Technologies 8,708 49.67 846 20.48% 163 40.51
Nephrocare Health Services 6,657 79.69 1,023 32.93% 77 35.51
Suraksha Diagnostic 1,849 51.63 314 22.55% 31 65.77
Krsnaa Diagnostics 1,796 17.83 816 9.90% 101 50.95
3B BlackBio DX 1,393 24.11 142 27.17% 61 68.55
One Global Service Provider 1,044 14.38 499 237.48% 70 45.89
Health X Platform 907 -34.21 1,319 12.68% -3 37.93

Krsnaa Diagnostics Company Announcements - News & Reports Screener

Screen KRSNAA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 5, 2026.

The next most recent announcements are dated October 5, 2026 and September 26, 2026.

Date Update Actions
2026-10-05 Announcement Under Regulation 30 (6) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-10-05 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-26 Closure of Trading Window -
2026-09-18 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-09-16 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Execution Of Concession Agreement For PET-CT Diagnostic Facilities In Punjab -
2026-09-11 Intimation - Regulation 36(1)(B) Of The SEBI Listing Regulations -
2026-09-09 Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-09-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-05 Business Responsibility and Sustainability Reporting (BRSR) -
2026-09-05 Reg. 34 (1) Annual Report. -
2026-09-05 Notice Of 16Th Annual General Meeting Of Krsnaa Diagnostics Limited To Be Held On Monday September 28 2026 At 11:00 Hrs. (IST) -
2026-09-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-28 Corrigendum To The Notice Of Postal Ballot -
2026-08-26 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-08-20 Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - General Updates -
2026-08-19 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-08-19 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-18 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-08-15 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹559.35, within a 52-week range of ₹520.30 to ₹826.80. The P/E ratio is 17.83 and the P/B ratio is 1.77, with earnings per unit of ₹31.30. Market capitalisation stands at ₹1,795.80 Cr and the dividend yield is 0.37%. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.